• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Endologix

Endologix looks to raise $25m in stock offering

August 14, 2019 By Nancy Crotti

Endologix (NSDQ:ELGX) has registered a stock offering of up to $25 million, according to a regulatory filing. The Irvine, Calif.-based company has engaged Piper Jaffray to offer more than 22.2 million shares of common stock at $6.45 per share. Proceeds will be used for manufacturing, clinical trials, R&D, sales and marketing expenses, general and administrative […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Funding Roundup, News Well, Research & Development, Wall Street Beat Tagged With: Endologix

Endologix shares dip on Q2 loss of $27.1 million

August 9, 2019 By Nancy Crotti

Shares in Endologix (NSDQ:ELGX) slipped by 8% to $6.06 apiece in midday trading today following yesterday’s second-quarter results that beat The Street on earnings expectations and sales. The Irvine, Calif.-based company reported a net loss of $27.1 million or -$1.50 per share on sales of $36.24 million for the three months ended June 30, 2019, […]

Filed Under: Blog, Business/Financial News, News Well, Wall Street Beat Tagged With: Endologix

Endologix closes $52m offering, debt refinancing deal

April 4, 2019 By Fink Densford

Endologix (NSDQ:ELGX) has closed a $52.2 million offering and debt exchange agreements with certain holders of its senior convertible notes for approximately $73.4 million, according to an SEC filing. In its offering deal, announced earlier this week, the Irvine, Calif.-based company said it floated approximately 7.9 million new shares of its common stock at a price of […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Endologix

Endologix inks debt refinancing deal, looks to raise $52m

April 2, 2019 By Fink Densford

Endologix (NSDQ:ELGX) said today that it is looking to raise $52 million in a new offering of its common shares and that it inked debt exchange agreements with certain holders of its senior convertible notes. In its private placement deal, the Irvine, Calif.-based company said it plans to float approximately 7.9 million new shares of its […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Endologix

Endologix readies for 1-for-10 reverse split

March 6, 2019 By Sarah Faulkner

Endologix (NSDQ:ELGX) said yesterday that its board of directors set the ratio for its reverse stock split at 1-for-10. Beginning today, Endologix’s common stock will trade on the Nasdaq Global Select market on a reverse stock split-adjusted basis, the Irvine, Calif.-based company reported. Following the reverse split, there will be roughly 10.3 million shares of issued […]

Filed Under: Business/Financial News, Featured, Stent Grafts, Wall Street Beat Tagged With: Endologix

Endologix misses the mark with Q4, 2018 numbers

February 27, 2019 By Brad Perriello

Endologix (NSDQ:ELGX) this week posted fourth-quarter and full-year results that missed the consensus forecasts for sales and earnings for both periods. The Irvine, Calif.-based stent graft maker’s losses grew 78.7% to -$26.0 million, or -26¢ per share, on sales growth of -18.6% to $24.0 million for the three months ended Dec. 31, 2018, compared with the […]

Filed Under: MassDevice Earnings Roundup, Stent Grafts, Wall Street Beat Tagged With: Endologix

Endologix shareholders approve reverse split

February 25, 2019 By Fink Densford

Endologix (NSDQ:ELGX) shareholders last week approved an upcoming reverse split of the company’s shares, according to a recently posted SEC filing. Shareholders in the Irvine, Calif.-based company voted to approve a reverse stock split “at a ratio not less than 1-for-5 and not greater than 1 for-10,” according to the SEC filing. The exact ratio has not yet been […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Endologix

CE Mark suspended for Endologix Nellix stent graft

January 23, 2019 By Fink Densford

Endologix (NSDQ:ELGX) said yesterday that the CE Mark approval for its Nellix stent graft system designed for treating abdominal aortic aneurysms was suspended by its notified body, GMED. The move follows a halt to unrestricted sales of the stent grafts and a voluntary recall of all existing inventory that the Irvine, Calif.-based company announced earlier this month. […]

Filed Under: Featured, Regulatory/Compliance, Stent Grafts, Vascular Tagged With: Endologix

JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019

January 15, 2019 By Fink Densford

JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]

Filed Under: Business/Financial News, Featured Tagged With: apyxmedical, biogennix, Cardiac Dimensions, Cardiovascular Systems Inc., Coorstek, Covidien, DaVita Inc., Digirad Corp., Endologix, ev3 Inc., Integra LifeSciences, Intuitive Surgical, InVivo Therapeutics, JenaValve, Johnson and Johnson, Medtronic, mentice, Micrus Endovascular Corp., Natus Medical Inc., Outset Medical, Patterson Companies, ReVision Optics Inc., Solace Therapeutics, Sonova Holding AG, Xtant Medical

Si-Bone tops estimates with Q4 prelims | Wall Street Beat

January 7, 2019 By Sarah Faulkner

Si-Bone (NSDQ:SIBN) said today that it expects to record fourth-quarter sales of $15.4 million to $15.6 million, up 12 – 13% from the same period last year. The company pegged its full-year sales for 2018 between $55.2 million and $55.4 million, up 15% from 2017. Analysts on Wall Street are expecting Si-Bone to post Q4 sales […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Alphatec, Endologix, Luminex, Nevro Corp., Si-Bone

Endologix recalls Nellix stent graft, bans off-label use

January 4, 2019 By Brad Perriello

Endologix (NSDQ:ELGX) said today that it’s halting the unrestricted sale of its Nellix stent graft for treating abdominal aortic aneurysms and limiting its use to pre-screened patients under a clinical protocol. “We monitor the performance of the Nellix system through clinical trials, our complaint monitoring system, physician interaction and available publications,” CMO Dr. Matt Thompson said […]

Filed Under: Featured, Recalls, Regulatory/Compliance, Stent Grafts Tagged With: Endologix

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 10
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS